Glimepiride/Pioglitazone Hydrochloride

Product Name :
Glimepiride/Pioglitazone Hydrochloride

Search keywords :
Pioglitazone

drugId :
null

Target Vo:
Sulfonylurea receptor

Target Vo Short Name :
SUR

Moa_Name:
KATP channels blockers

First Approval Country :
United States

First Approval Date Filter:
2006

Origin Company_Name :
Takeda

Active Company_Name :
Cheplapharm Arzneimittel Gmbh

Active Indication_Name:
Diabetes Mellitus, Type 2

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Toripalimab custom synthesis
Phospho-mTOR (Ser2448) Rabbit mAb Autophagy
Wnt3a Antibody: Wnt3a Antibody is a non-conjugated and Rabbit origined Polyclonal antibody about 39 kDa, targeting to Wnt3a . It can be used for WB, IHC-P, IHC-F, IF, ELISA assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts